Araştırma Makalesi

Outcome of UVA-Riboflavin collagen cross-linking of cornea in patients with keratoconus

Cilt: 43 Sayı: 3 30 Eylül 2018
Ayşe Sevgi Karadağ , Burak Bilgin , Nusret Özdemir
PDF İndir
EN TR

Outcome of UVA-Riboflavin collagen cross-linking of cornea in patients with keratoconus

Abstract

Purpose: In this study, we aimed to show changes of central corneal thickness and effects of treatment on visual acuity after corneal collagen cross-linking in keratoconus patients.
Materials and Methods: 26 eyes of 51 patients with keratoconus who undergone corneal collagen cross-linking were included in to the study. Central corneal thickness measurements and best corrected visual acuity were recorded before and after 1st and 6th month of corneal collagen cross-linking operation.
Results: Mean central corneal thickness measurements were recorded as; 435,43±44,35 μm,  376,68±66,55 μm and 392,62±64,21 μm before and after 1st and 6th month of corneal collagen cross-linking, respectively. There was a statistically significant difference between pre-op and postop 1st month, pre-op and postop 6th month and post-op 1st month and post-op 6th month central corneal thickness measurements. Also, there was a statistically significant increase in best corrected visual acuity after the operation.
Conclusion: There was a statistically significant difference between pre-op, post-op 1st month and postop 6th month central corneal thickness and best corrected visual acuity measurements.

Keywords

Keratoconus,Corneal Collagen Cross-Linking,Riboflavin,UVA

Kaynakça

  1. 1. Espandar L, Meyer J. Keratoconus: overview and update on treatment. Middle East Afr J Ophthalmol 2010;17:15-20.
  2. 2. Edwards M, McGhee C.N, Dean S. The genetics of keratoconus. Clin Experiment Ophthalmol 2001; 29:345-51.
  3. 3. Smith VA, Hoh HB, Littleton M, Easty DL. Over-expression of a gelatinase A activity in keratoconus. Eye (Lond) 1995; 9:429-33.
  4. 4. Smith VA, Easty DL. Matrix metalloproteinase 2: involvement in keratoconus. Eur J Ophthalmol 2000; 10:215-26.
  5. 5. Parkin BT, Smith VA, Easty DL. The control of matrix metalloproteinase-2 expression in normal and keratoconic corneal keratocyte cultures. Eur J Ophthalmol 2000; 10:276-85.
  6. 6. Ku JY, Niederer RL, Patel DV, Sherwin T, McGhee CN. Laser scanning in vivo confocal analysis of keratocyte density in keratoconus. Ophthalmology 2008;115(5):845-50.
  7. 7. Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998; 42(4):297-319.
  8. 8. Barnett M, Mannis MJ. Contact lenses in the management of keratoconus. Cornea 2011;30(12):1510-6.
  9. 9. Dahl BJ, Spotts E, Truong JQ. Corneal collagen cross-linking: An introduction and literature review. Optometry 2012;83(1):33-42.
  10. 10. Arne JL, Fournié P. Keratoconus, the most common corneal dystrophy. Can keratoplasty be avoided? Bull Acad Natl Med 2011;195(1):113-29.

Kaynak Göster

MLA
Karadağ, Ayşe Sevgi, vd. “Outcome of UVA-Riboflavin collagen cross-linking of cornea in patients with keratoconus”. Cukurova Medical Journal, c. 43, sy 3, Eylül 2018, ss. 589-93, doi:10.17826/cumj.336939.